USPTO 2015–2025 USPTO PatentsView US Corporation

Tela Bio, Inc.

USPTO PatentsView assignee record - 25 granted patents across 8 technology areas, recorded in grant years 2017–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).

RSS updates for this company

The verdict

According to USPTO PatentsView, Tela ranks #12,258 of 49,997 tracked US assignees by granted-patent volume, with 25 patents across 8 technology areas.

#12,258
of 49,997 US assignees by volume
Top 20%
by Innovation Score (46.7/100)
22.1
avg claims per patent
+100%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R12258 · US Corporation #12,258 · 25 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-SURGE · BOOK-FULL

  • GRANTS-SMALL 25 grants
  • UPPER-Q #12,258/49,997
  • PHOTO-FINISH Tech Friends
  • CPC-NARROW A61F · 8 areas
  • INNOV-PAR 46.7/100
  • CLAIMS-DENSE 22.1 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-SURGE +100% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Tech Friends, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Tela’s 46.7 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Tela

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Tela's Innovation Score is 46.7/100 (top 20% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Tela?

Each dot is one of Tela’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Tela’s own 22.1 claims/patent is ABOVE the 12.6 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Tela vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 24.924.92525.1 510152025 Granted patents (volume) Avg claims / patent Tech Friends, Inc. - 25, 20.44Tech FriendsTechway Industrial Co., Ltd. - 25, 12.56Techway IndustrialTeijin Frontier Co., Ltd. - 25, 11.2Teijin FrontierTEL FSI, Inc. - 25, 14.44TEL FSITHE Hi-tech Robotic Systemz Ltd - 25, 8.08THE Hi-tech Robot…THE Parallax Group International, LLC - 25, 10.08THE Parallax Grou…Total Raffinage Marketing - 25, 18.84Total Raffinage M…Tri-force Management Corporation - 25, 19.04Tri-force Managem…Tela Bio, Inc. - 25, 22.08Tela Bio
Tela vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Tela's grants concentrate

Tela Bio, Inc. is a focused PatentsView assignee: 8 CPC subclasses with 88% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2024 (5 grants) versus a trough of 2 in 2017. By volume, Tela sits between Tech Friends, Inc. and Tri-force Management Corporation.

Tela's three-year grant acceleration

Tela Bio, Inc. shows 11 grants in 2022–2024 against only 6 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Tela's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Tela holds 25 patents at rank #12,252, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Tela

By rank, the assignees closest to #12,252 in granted patent volume.

Leaders in A61F (Filters Implantable Into Blood Vessels)

Other assignees with the most granted patents in Tela's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Tela, neither rank-band nor same-CPC leaders (those blocks stay above). In A61F (Filters Implantable Into Blood Vessels), Tela ranks #296 of 3,082 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (47 here).

Tela's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

47 Top 20% higher than 80% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

123456 20172018201920202022202320242025 4
USPTO utility patent grants by year · 2017–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table
Tela Bio, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2017 2 8.0%
2018 2 8.0%
2019 3 12.0%
2020 3 12.0%
2022 4 16.0%
2023 2 8.0%
2024 5 20.0%
2025partial year 4 16.0%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Tela Bio, Inc.'s patent record in context - here's where to go next.

  • Tela Bio, Inc.'s lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 88% of its portfolio - see every assignee active in that class. Explore A61F
  • Ranked #12,258 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Tela Bio, Inc. against Tech Friends, Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 46.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.